He also advised colleges and universities, K-12 schools, early childhood centers, churches, and other organizations regarding their COVID-19 policies and protocols, particularly with respect to vaccines. Ned Lamont's COVID-19 Vaccine Advisory Group and chair of its Science Subcommittee.
He is a member of The Lance t Commission on Vaccine Acceptance in the United States and the New England Comparative Effectiveness Public Advisory Council for the Institute for Clinical and Economic Review (ICER).ĭuring the COVID-19 pandemic, Schwartz was a member of Connecticut Gov. House Oversight Subcommittee on Economic and Consumer Policy, the National Vaccine Advisory Committee, and the Presidential Commission for the Study of Bioethical Issues. His research, analysis, and perspectives have appeared in the New York Times, Washington Post, CNN, NPR, BBC, Time, and elsewhere. health care system, pharmaceuticals and the FDA, science advice to government, and related topics. Schwartz regularly teaches courses and gives lectures on vaccination issues, health policy and the U.S. Other ongoing projects examine how policy-makers, regulators, payers, physicians, and patients evaluate and respond to the risks, benefits, and costs of medical interventions. This project is supported by the National Institutes of Health.
Among his current research projects is a book, Solicited Advice : Expert Committees and Medicine in Modern America, that examines the emergence, evolution, and continuing influence of expert advisory committees in American medicine and public health from the 1960s to the present, particularly regarding pharmaceuticals, vaccines, and screening technologies. He is also an author of the chapter titled “Ethics” in Plotkin's Vaccines, the leading textbook of vaccine science and policy, and editor of Vaccination Ethics and Policy: An Introduction with Readings. Schwartz's publications have appeared in The New England Journal of Medicine, The Journal of the American Medical Association (JAMA), The American Journal of Public Health, BMJ, The Lancet, Health Affairs, and elsewhere. He holds a secondary appointment in the Section of the History of Medicine at the Yale School of Medicine and is also affiliated with Yale's Institution for Social and Policy Studies and Program in the History of Science and Medicine. The overall focus of his work is on the ways in which evidence is interpreted, evaluated, and translated into regulation and policy in medicine and public health. His research examines vaccines and vaccination policy, decision-making in medical regulation and public health policy, and the structure and function of scientific expert advice to government. Schwartz is an Associate Professor in the Department of Health Policy and Management at the Yale School of Public Health.
0 kommentar(er)
